Publication: 3486

Publication: 3486

Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Urol vol 206 (2) 319-324

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:: 10

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Sanofi
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233191, UG1CA233290

Corr. Author:
Authors:: James A. Eastham Glenn Heller David W. Hillman Olwen M. Hahn J. Kellogg Parsons James L. Mohler Eric J. Small Michael Morris

Networks:: CA249, CA824, LAPS-IL057, LAPS-NY016, LAPS-NY158

Study: CALGB-90203
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: testosterone, radical prostatectomy, prostatic neoplasms, neoadjuvant therapy